Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>80 Mile 0.98p £48.56m (80M.L) The AIM, FSE, and OTC listed exploration and development Company with projects in Greenland, Finland and Italy confirms that the SEC has approved the proposed acquisition by Pelican Acquisition Corporation (PELI), the NASDAQ-listed special purpose acquisition company, of Greenland Exploration Limited, and March GL, and, subject only to shareholder approval, is now set to start trading on NASDAQ as Greenland Energy Company.</li>
<li>Under the terms of 80 Mile's definitive joint venture agreement, PELI is entitled to earn up to a 70% working interest in Jameson by funding 100% of the costs associated with up to two exploration wells, each to a minimum depth of approximately 3,500 metres.</li>
<li>80 Mile will retain a 30% interest in Jameson through its wholly owned subsidiary White Flame Energy A/S.</li>
</ul>


80 Mile 0.98p £48.56m (80M.L) The AIM, FSE, and OTC listed exploration and development Company with projects in Greenland, Finland and Italy confirms that the SEC has approved the proposed acquisition by Pelican Acquisition Corporation (PELI), the NASDAQ-listed special purpose acquisition company, of Greenland Exploration Limited, and March GL, and, subject only to shareholder approval, is now set to start trading on NASDAQ as Greenland Energy Company.
Under the terms of 80 Mile's definitive joint venture agreement, PELI is entitled to earn up to a 70% working interest in Jameson by funding 100% of the costs associated with up to two exploration wells, each to a minimum depth of approximately 3,500 metres.
80 Mile will retain a 30% interest in Jameson through its wholly owned subsidiary White Flame Energy A/S.


Hybridan Small Cap Feast: 19 February 2026

<ul>
<li>24th October: Sterling Digital, the bitcoin mining business, has announced its intention to seek admission on the Access segment of the Aquis Stock exchange.</li>
<li>The Company’s objective is to deliver sustainable long-term growth via compounding bitcoin exposure through cheapest-in-class mining and active management of bitcoin reserves.</li>
<li>The Company expects to raise money and Admission on or around 11 November 2025. </li>
</ul>


24th October: Sterling Digital, the bitcoin mining business, has announced its intention to seek admission on the Access segment of the Aquis Stock exchange.
The Company’s objective is to deliver sustainable long-term growth via compounding bitcoin exposure through cheapest-in-class mining and active management of bitcoin reserves.
The Company expects to raise money and Admission on or around 11 November 2025. 


Hybridan Small Cap Feast: 04 November 2025

Aurrigo International  / Equity Bottom-Up

<ul>
<li>The holding company for TIAA Limited, a specialist business assurance provider operating across the Housing, Healthcare, Government, Education, Charities, and other sectors, announced its consolidated final results and proposed dividend for the year ended 31 March 2025.</li>
<li>Total Revenue increased 7.7% to £10.0m (2024: £9.3m) and there was a 74% increase in profit before taxation to £0.8m (2024: £0.5m).</li>
<li>Cash balances were £1.1m as of 31 March 2025 (2024: £1.1m) with a proposed final dividend payment increase of 15.2% to 1.14 pence per share (2024: 0.99 pence) to be paid in September 2025.</li>
</ul>


The holding company for TIAA Limited, a specialist business assurance provider operating across the Housing, Healthcare, Government, Education, Charities, and other sectors, announced its consolidated final results and proposed dividend for the year ended 31 March 2025.
Total Revenue increased 7.7% to £10.0m (2024: £9.3m) and there was a 74% increase in profit before taxation to £0.8m (2024: £0.5m).
Cash balances were £1.1m as of 31 March 2025 (2024: £1.1m) with a proposed final dividend payment increase of 15.2% to 1.14 pence per share (2024: 0.99 pence) to be paid in September 2025.


<ul>
<li>The specialist in currency risk management and alternative banking, reports finals to December 2024.</li>
<li>Its revenue is £50.3m up from £49.9m, with growth in the number of clients offset by a reduction in average spend.</li>
<li>The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m. </li>
</ul>


The specialist in currency risk management and alternative banking, reports finals to December 2024.
Its revenue is £50.3m up from £49.9m, with growth in the number of clients offset by a reduction in average spend.
The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m. 


Surface Transforms PLC - Duplicate of Hybridan Small Cap Feast: 02/04/2025

Research from Hardman & Co, Hardman & Co

Hardman & Co

Research from Hardman & Co

Investment research on quoted companies and funds

Hardman & Co is a multi-disciplinary financial consultancy and investment research firm, employing highly experienced analysts and professionals with a broad range of capital markets expertise. Our clients are public and private businesses as well as fund managers, ranging from start-ups to £1 billion+ market capitalisations. Hardman & Co offers corporate research & consultancy, serving the needs of both public and private companies. We produce gold-standard research with a global reach for trading and investment companies, as well as providing market commentary and analysis. In addition, we carry out a number of bespoke investment-related assignments, including due diligence on bond listings, assessments of private company valuations and other corporate advisory services. We engage with the market through traditional and digital media, offering illuminating video content on corporate management strategy, results communication, interviews and in-house sector discussion.

<ul><li>For two years running, the Hardman & Co Healthcare index has declined, underperforming both the FTSE 100 and the FTSE All-Share indices.</li><li>This is quite unusual for healthcare stocks.</li><li>Apart from the general economic influences, which have made institutions more risk-averse, there was a common knowledge that several companies were in need of additional working capital; so, share prices were marked down in anticipation of equity raises.</li></ul>

For two years running, the Hardman & Co Healthcare index has declined, underperforming both the FTSE 100 and the FTSE All-Share indices.This is quite unusual for healthcare stocks.Apart from the general economic influences, which have made institutions more risk-averse, there was a common knowledge that several companies were in need of additional working capital; so, share prices were marked down in anticipation of equity raises.

Tissue Regenix Group PLC - Hardman & Co Insight: Survival of the UK life sciences sector

United Kingdom

Genedrive PLC operates as a biotechnology company. The Company offers diagnostic platform to offer quick and sensitive molecular analysis within an ultra compact unit. Genedrive provides its services in the United Kingdom and United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Genedrive PLC (GDR LN)

Hybridan Small Cap Feast: 19 February 2026

The AIM, FSE, and OTC listed exploration and development Company with projects in Greenland, Finland and Italy confirms that the SEC has approved...

Hybridan

Hybridan Small Cap Feast: 04 November 2025

24th October: Sterling Digital, the bitcoin mining business, has announced its intention to seek admission on the Access segment of the Aquis Stock...

Hybridan

Hybridan Small Cap Feast: 11/08/2025

The holding company for TIAA Limited, a specialist business assurance provider operating across the Housing, Healthcare, Government, Education,...

Hybridan

Surface Transforms PLC - Duplicate of Hybridan Small Cap Feast: 02/04/2025

The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m.

Hybridan

Tissue Regenix Group PLC - Hardman & Co Insight: Survival of the UK life sciences sector

For two years running, the Hardman & Co Healthcare index has declined, underperforming both the FTSE 100 and the FTSE All-Share indices. This...

Hardman & Co

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)